Anne-Marie Haaparanta

Anne-Marie Haaparanta has had a varied career in the field of technology and biosciences. Anne-Marie began their career in 2005 as a Researcher and Research Assistant at Tampere University of Technology. In 2015, they took on a Postdoctoral Researcher role at BioMediTech - institute of biosciences and medical technology. In 2017, they joined Askel Healthcare Ltd as the Chief Technology Officer, where they are responsible for commercializing the best possible solution for treating damaged cartilage.

Anne-Marie Haaparanta attended Tampere University of Technology from 1965 to 2018.